Back to top
more

IPSEN (IPSEY)

(Delayed Data from OTC)

$30.16 USD

30.16
365

-0.38 (-1.24%)

Updated Apr 25, 2024 11:00 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Is Cybin Inc. (CYBN) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Cybin Inc. (CYBN) and IPSEN (IPSEY) have performed compared to their sector so far this year.

Is IPSEN (IPSEY) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how IPSEN (IPSEY) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.

Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y

by Zacks Equity Research

Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.

Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More

by Zacks Equity Research

Regulatory and other updates from Epizyme (MRNA) and Kezar (KZR) are a few key highlights from the biotech sector during the past week.

Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen

by Zacks Equity Research

Ipsen, through its wholly-owned subsidiary, is set to acquire Epizyme (EPZM) for $1.45 per share, in cash, along with a contingent value right of $1 per share. The transaction is likely to close by third-quarter 2022.

ASRT vs. IPSEY: Which Stock Is the Better Value Option?

by Zacks Equity Research

ASRT vs. IPSEY: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Daimler, E.ON, BASF, Telecom Italia and Ipsen

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Daimler, E.ON, BASF, Telecom Italia and Ipsen

    Tirthankar Chakraborty headshot

    ECB Paves Way for More Stimulus! Grab 5 European Stocks Now

    by Tirthankar Chakraborty

    ECB leaves room for more stimulus measures and an uptick in Eurozone economic growth make European stocks more alluring

      Bellicum Pharmaceuticals (BLCM) in Focus: Stock Moves 13.8% Higher

      by Zacks Equity Research

      Bellicum Pharmaceuticals (BLCM) was a big mover last session, as the company saw its shares rise nearly 14% on the day.

        Why IPSEN (IPSEY) Could Be an Impressive Growth Stock

        by Zacks Equity Research

        IPSEN (IPSEY) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

          What's in the Cards for Merrimack (MACK) in Q1 Earnings?

          by Zacks Equity Research

          Merrimack Pharmaceuticals, Inc. (MACK) is expected to report first-quarter 2017 results around May 1. Last quarter, Merrimack missed bottom line expectations

            Commercial Vehicle Group, MTS Systems, Ipsen, AXA and Arkema highlighted as Zacks Bull and Bear of the Day

            by Zacks Equity Research

            Commercial Vehicle Group, MTS Systems, Ipsen, AXA and Arkema highlighted as Zacks Bull and Bear of the Day

              John Blank headshot

              The U.S.A. and China Start Talking: Global Week Ahead

              by John Blank

              China's President Xi meets President Trump in Florida later this week, and traders will watch it closely.